Research
- Research
- Biosimilars
- Drug Abuse Prevention
- Drug Adherence Programs
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Employers, Unions, & Insurers
- FEHB Program
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Health Insurance Marketplace (ACA)
- Home Delivery of Drugs
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- REMS Management
- Specialty Benefit Design
- Specialty Pharmacies
- Specialty Pharmacy Networks
- TRICARE
“Patent Thickets” are Anti-Competitive and Lead to Higher Drug Costs
May 11, 2021
Brand drug manufacturers extend the exclusivity of their drugs beyond the end of their initial exclusivity period by filing multiple...
Brand Drug Manufacturers’ Anti-Competitive Behavior: Patent Thicket
May 11, 2021
Brand drug manufacturers use a variety of strategies to extend the exclusivity of their drugs beyond the end of their...
Estimated cost of potential “frozen formulary” legislation
February 02, 2021
“Frozen formulary” legislation refers to regulations proposed by state legislators that would prohibit a pharmacy benefit manager (PBM) or health...
January 25, 2021
A new report, “Pharmacy Services Administrative Organizations (PSAOs) and their Little-Known Connection to Independent Pharmacies,” sheds light on the role...
January 07, 2021
A new white paper by the Pharmacy Benefit Management Institute (PBMI) outlines ways that some drug manufacturers undermine formulary and...
Impact of Medicare Part D Drug Manufacturer Rebates at the Point-of-Sale
November 18, 2020
A new report by Milliman shows that over the 10-year period 2022-2031, if all manufacturer rebates were reflected at the...
Negative Economic Impact of Restricting Drug Rebates in Medicare Part: Matrix Global Advisors
September 02, 2020
“Negative Economic Impact of Restricting Rebates in Medicare Part D,” by Alex Brill of Matrix Global Advisors (MGA), examines recent...
Americans’ Opinions on the Elimination of Rebates in Medicare Part D
August 13, 2020
A majority of seniors say they are satisfied with their prescription drug coverage… Read More...
Insulins: Managing Costs With Increasing Manufacturer Prices
August 11, 2020
Insulin list prices have escalated dramatically during the past 5-10 years. This is due to only three manufacturers controlling the...
Survey Says: Americans 65+ Disapprove of President Trump’s Rebate Rule
August 10, 2020
In a recent survey conducted by Morning Consult on behalf of the Coalition for Medicare Choices, we asked voters 65+...
EMPLOYERS ARE OVERWHELMINGLY SATISFIED WITH THEIR PBMs
July 11, 2020
The vast majority of employers say PBMs are effective at reducing drug costs for their organizations....
Key Findings from Survey of Benefit Managers
June 25, 2020
Our national survey of benefit managers and human resources directors, conducted online June 4-9, 2020, consists of 250 respondents drawn...